'Hope on horizon' as new drugs tested for Alzheimer's treatment
Dementia experts have said that "hope is on the horizon" after a new review shows a rise in the number of potential drugs that could treat or prevent Alzheimer's disease.
Some 138 new treatments are being assessed for the treatment and prevention of Alzheimer's.
A third of drugs currently being trialled are "repurposed" medications that are already being used to tackle other diseases, including diabetes, multiple sclerosis and cholesterol, according to the new review.
One such trial is assessing whether semaglutide, the main ingredient for the weight loss and diabetes drug Ozempic and weight loss drug Wegovy, can slow the progression of dementia.
And four late-stage trials are looking at preventing disease.
Experts said that drugs targeting amyloid protein build up in the brain, such as lecanemab and donanemab, are "only one part of the overall strategy" as they expressed excitement over the variety of new drugs, which are being tested among patients.
The new review of Alzheimer's disease in clinical trials in 2025 found 182 clinical trials assessing the impact of 138 drugs.
The number of trials represents an 11% increase on the previous year, according to the review, which was led by an expert from the University of Nevada in the US and has been published in the journal Alzheimer's and Dementia: Translational Research and Clinical Interventions.
Commenting on the paper, Dr Sheona Scales, director of research at Alzheimer's Research UK, said: "This year has really given us real cause for optimism."
She said that as well as more drugs coming through the pipeline, the treatment targets are "more diverse" and "looking at all stages of the disease".
She added: "What this paper is showing us is that the pipeline of drug development is growing, it's diversifying and accelerating."
"This latest report shows us that there is hope on the horizon for people with Alzheimer's, building on lecanemab and donanemab."
Dr Emma Mead, chief scientific officer of the Oxford Drug Discovery Institute, added: "Today we are at a tipping point in dementia research as we understand more and more about the diseases that drive dementia.
"This gives us opportunities to slow and ultimately stop this devastating condition and today's announcement demonstrates that researchers are able to translate these understandings towards potential new treatments."
James Rowe, professor of cognitive neurology at the University of Cambridge and consultant neurologist, said: "What strikes me is not just the number of new drugs, which is increasing year on year, but their range of targets (and) the range in which they work, giving us multiple shots on goal."
On the drugs which are being investigated for the prevention of disease, Prof Rowe said: "One of the most exciting things of this report is the number of large-scale late-stage trials on prevention.
"And the aspiration to prevent, not just treat, is starting to be seen in the figures we see in these charts today."
He added: "One way this can work is you take a treatment that you show to be working in people with symptoms with the illness, and then you simply bring it forward by some years.
"The ones that are in trial at the moment are really... bringing forward an effective treatment to earlier stage."
For instance, people with a genetic risk of Alzheimer's could receive some drugs earlier to see if they protect against the disease.
On the repurposing of current drugs, Dr Mead said that it can usually take ten to 15 years for new drugs to be tested and approved for use.
"Being able to repurpose drugs licensed for other health conditions could help to accelerate progress and help to open up other avenues to prevent or treat dementia causing diseases," she said.
"A really promising example of this is the drug semaglutide, which is currently being trialled in people with mild cognitive impairment."
Meanwhile, academics said lecanemab and donanemab, which can be used for treating mild cognitive impairment in Alzheimer's patients, are an "important first step" in the battle against the disease.
The treatments were initially approved for UK use by regulators but then deemed not cost-effective for NHS use.
The National Institute for Health and Care Excellence (NICE) is taking more evidence on donanemab and lecanemab and is expected to announce its decision in the summer.
Dr Scales added: "Lecanemab and donanemab have represented a huge leap forward in our understanding and ability to be able to treat Alzheimer's disease.
"What they've done is they've proved that we're able to modify the course of Alzheimer's disease, and what that has done is opened up the door to future treatments that we hope are more effective, easier to deliver and able to deliver for our patients."
She said studies are showing "even more complexities" around Alzheimer's and that in the future, people may be treated with a combination of drugs, depending on when they are diagnosed and the type of dementia they have.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Irish Sun
2 hours ago
- The Irish Sun
I lost 12lbs & full dress size in weeks on Mounjaro after changing jabs but surprising side effect transformed my life
IRISH mum Sandra Keogh spent hundreds of euros EVERY month on Doritos as her eating "addiction" spiralled out of control. But now the mum-of-four is thriving thanks to a "bizarre" fat jabs side effect and her weight loss has given her husband "a renewed twinkle in his eye". 4 Sandra was a big fan of 'trash food' but she's now saving a fortune 4 The mum, 37, said her food bill was 'through the roof' 4 She has lost 12 pounds in just 8 weeks The former weight loss consultant, 37, said she needed to urgently make a change but had already tried all of the usual routes. She said: "I felt unable to find the will to care what I was shoving in my mouth. "It was compounded by the fact that I knew what I should be doing I just felt useless. I had to try something else." But she had a light bulb moment one day after sitting down to watch a bit of reality TV. The "So after a while when I heard about availability here, I went and spoke to my doctor because I haven't had diabetes but I just needed something. "I knew what had to be done, but I didn't have the willpower or the motivation to do anything. "I started Ozempic in November 2023, after the doctor thought it was a great idea. "I was on it until February this year and when I heard Mounjaro was coming in, I was eager to swap because I had lost 33 pounds on Ozempic and I kind of had stalled. "When I heard that Mounjaro was going to be approved for a weight loss here in Ireland, I thought, 'Right, I'm going to try and get it'. "I started taking it on the 25th of March and I began losing weight again." Sandra, who shares her journey on TikTok, said she was addicted to eating Doritos daily but a positive side effect of Mounjaro means she no longer has the desire to eat them. She said: "As far as day to day, you are probably wondering what exactly it does to me, but I find personally, it takes away all kind of interest that you would have in food. I lost 98lb on Mounjaro but it's surprise side benefit that's been life-changing "I was a grazer, food was so urgent, Doritos, especially. "I was getting up every evening, dragging my young one to the shop and just to go get Doritos. It felt like an urgency, a need. "I'd have a bag every night plus a Marvellous Creations bar – the big one, I didn't do small. "I was desperate for it, and the medications just take all that away, but I haven't changed what I eat. "I just eat when I'm hungry and I would fill my plate the way I always used to, but I would never ever get through a full plate of dinner the way I used to and I've lost 12 pounds now in the last 8.5 weeks. "So, it's been really, really positive." Sandra, who has lost three stone in total, said her grocery bill was "through the roof" as she satisfied her cravings. She said: "My husband was like, 'Where's all the money going?' and I was like we go to the shop every day after school and then I could have been back at the shop in the evening so it could have been €20 a day just on trash. "A bag of Doritos is €4, and a bar of Marvellous Creations is €4 and you're buying a can of Red Bull or Coca Cola and then stuff for the kids, it was easily €20." What are the side effects of weight loss jabs? Like any medication, weight loss jabs can have side effects. Common side effects of injections include: Nausea : This is the most commonly reported side effect, especially when first starting the medication. It often decreases over time as your body adjusts. Vomiting : Can occur, often in conjunction with nausea. Diarrhea : Some people experience gastrointestinal upset. Constipation : Some individuals may also experience constipation. Stomach pain or discomfort : Some people may experience abdominal pain or discomfort. Reduced appetite : This is often a desired effect for people using Ozempic for weight loss. Indigestion : Can cause a feeling of bloating or discomfort after eating. Serious side effects can also include: Pancreatitis : In rare cases, Ozempic may increase the risk of inflammation of the pancreas, known as pancreatitis, which can cause severe stomach pain, nausea, and vomiting. Kidney problems : There have been reports of kidney issues, including kidney failure, though this is uncommon. Thyroid tumors : There's a potential increased risk of thyroid cancer, although this risk is based on animal studies. It is not confirmed in humans, but people with a history of thyroid cancer should avoid Ozempic. Vision problems : Rapid changes in blood sugar levels may affect vision, and some people have reported blurry vision when taking Ozempic. Hypoglycemia (low blood sugar) : Especially if used with other medications like sulfonylureas or insulin. Sandra also revealed her overall health has also improved as a result - and would recommend it to anyone looking to shed the pounds. She said: "As a former weight loss consultant a lot of what we did was educating people around eating cleanly and of course that's 100 per cent the right thing to do. "But sometimes when you eat cleanly, you start to think about the things you shouldn't and can't have. "Whereas with the weight loss medication, those thoughts and obsessions around food are gone. "I can't explain it, it's just the most bizarre feeling. I suppose it's addiction really isn't it?" And Sandra said her husband has noticed her progress - and has been showering her with compliments. She said: "My husband thankfully met me at my heaviest and has been supportive and loving no matter what weight I've been. "However, he does have a renewed twinkle in his eye and compliments come a bit more regular. I notice him noticing. "I'm not unrecognisable just yet but on my way there, but confidence wise though, people are definitely noticing the difference." 4 Sandra is feeling happier and healthier since starting her Mounjaro journey
Irish Independent
10 hours ago
- Irish Independent
Michael Mosley's family reflect on one year since TV doctor's death
Mosley, who died aged 67 while on holiday with his wife Dr Clare Bailey Mosley on the Greek island of Symi last year, was known for popularising diets and fronting science programmes. His wife wrote on Instagram: 'It's hard to believe that a year has passed since we lost Michael. Not a day goes by without thinking of him – his warmth, his laughter, his endless curiosity about the world, and his deep love for our family. 'This past year has been the hardest of our lives. Navigating the loss of someone so central to our hearts and our home has changed everything. We have missed him in the big moments and the small ones. But we have also felt incredibly supported. 'The outpouring of love, stories and memories from so many of you has meant more than we can ever say. We have taken real comfort in knowing just how many lives Michael touched – not only through his work, but through his kindness, humour, and deep desire to help people live well for longer.' The message thanked 'everyone who has reached out, shared their grief, and carried us with their compassion, thank you. Your messages, letters and acts of remembrance have helped us through the darkest days.' It continued: 'We are trying, as a family to look forward. To carry on the work Michael was so passionate about. To live with purpose and joy, as he would have wanted us to.' 'With love and deepest gratitude, Clare and the Mosley family.' We need your consent to load this Social Media content. We use a number of different Social Media outlets to manage extra content that can set cookies on your device and collect data about your activity. Please review your details and accept them to load the content Last month, the family set up a research project to honour his memory, announcing that a new clinical research fellowship will be established in partnership with King's College London and the Chronic Disease Research Foundation (CDRF) to help improve the nation's metabolic health. The Mosleys have been working with King's College London and the CDRF, who will administer the Michael Mosley Memorial Research Fund, to appoint a dedicated research scientist. Mosley, known for fronting BBC and Channel 4 documentaries on health and diet, popularised the 5:2 diet, a form of intermittent fasting, through his book The Fast Diet. ADVERTISEMENT His son Dr Jack Mosley, a GP registrar, who researched GLP-1 drug brands including Ozempic, Wegovy, Mounjaro and Zepbound with his father, has also written a book titled Food Noise: How Weight Loss Medication And Smart Nutrition Can Silence Your Cravings. In December, a coroner said Mosley's death was 'indeterminate' and 'unascertainable', adding that it 'was most likely attributable either to heatstroke (accidental) or non-identified pathological cause'. Mosley had presented BBC Radio 4's Just One Thing, and the BBC series Trust Me, I'm A Doctor, which looked at healthcare in Britain. He would regularly push his body during various programmes, and in a 2014 documentary he ingested tapeworms for six weeks. In a 2015 programme he made two black puddings out of his own blood to showcase its nutritional value. The BBC honoured the doctor-turned-science broadcaster with a day dedicated to him in July 2024, when presenters and audiences where encouraged to do 'just one thing' to improve their wellbeing. His wife Clare accepted the Hall of Fame Award at the British Podcast Awards on his behalf in September 2024.
Extra.ie
10 hours ago
- Extra.ie
Weight-loss injections linked to 'Ozempic baby' boom as fertility seems to increase
Women taking weight-loss jabs have been warned to use contraceptives or risk having unplanned 'Ozempic babies'. The UK's health watchdog, the Medicines and Healthcare products Regulatory Agency (MHRA), issued an alert this week telling women taking any slimming injection, including Ozempic and Wegovy, to use effective birth control. The injections have been linked to a 'baby boom', with women reporting online they have had surprise 'Ozempic babies' despite using contraception or having fertility issues in the past. Ozempic. Pic: Natalia GH/Shutterstock To date, the MHRA has received over 40 reports about pregnancy among women on the drugs. When approached Ireland's Health Products Regulatory Authority about figures here, the HPRA stated that it was made aware of six pregnancies following treatment with similar weight-loss drugs. The HSE has said it doesn't have any data on unplanned pregnancies linked to Ozempic or other GLP-1 receptor agonists used for weight loss, such as Mounjaro or Wegovy. However, it also said: 'Very common and common side effects include diarrhoea and vomiting, which could potentially impact on any medication taken orally', such as the Pill. Pic: Shutterstock Professor Donal O'Shea, HSE national clinical lead for obesity, said: 'If you respond to Ozempic and lose weight, you are more likely to populate. 'The mechanism by which weight loss makes you more fertile is that the weight loss leads to insulin sensitivity, and if you're more sensitive to your insulin, then your ovaries work better and you start ovulating again.' He continued: 'There's also an issue with how your stomach absorbs things like the oral contraceptive pill. For some women that may use it as their main contraceptive, it may well not be as effective. Ozempic. Pic: REX/Shutterstock 'We do routinely advise women that they stop Ozempic some months before attempting to conceive. The problem is many pregnancies are unplanned, so you can't always do that. If somebody gets pregnant on Ozempic, they should discontinue it immediately.' The HPRA operates the national adverse reaction reporting scheme, which tracks side effects from medicines. The authority said that, of the six pregnancies linked to weight-loss drugs, many were linked to drugs other than Ozempic. 'This product is a prescription-only medicine, and patients should discuss any queries or concerns regarding pregnancy with their doctor,' the HPRA stated. Meanwhile, those using the 'King Kong' of weight-loss jabs, Mounjaro, were told to 'double-up' their methods of contraception if using the Pill. 'Mounjaro may reduce the effectiveness of oral contraceptives in those who are overweight,' the MHRA alert read, adding that safe sex is 'especially important for the four weeks after starting Mounjaro and after any dose increase'. Officials added that women who become pregnant while using the medications must cease them immediately. Those who are breastfeeding are also advised to stop the injections.
